At USD 94.31 the long position in $EW has been closed on 31 October 2016. The realized 3-day profit before any taxes and fees is 2.39%.
Long position opened in Edwards Lifesciences (ISIN: US28176E1082) at USD 92.10 on 28 October 2016. The share price dropped significantly and became extremely oversold. On the other hand the analysts maintained positive expectation in connection with the mid-term performance of the company. Unfortunately no dividend is expected.